823 results on '"Gwak, Geum-Youn"'
Search Results
152. Hepatitis B virus DNA levels and overall survival in hepatitis B‐related hepatocellular carcinoma patients with low‐level viremia
153. FRI-165-No detectable resistance to tenofovir in patients with Adefovir- and Entecavir-resistant chronic hepatitis B after 240 weeks of treatment with tenofovir disoproxil fumarate monotherapy
154. Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
155. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
156. Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
157. Importance of a Diversity Committee in Advancing the Korean Society of Gastroenterology: A Survey Analysis
158. Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.
159. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
160. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
161. Percutaneous Radiofrequency Ablation of Small (1–2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography
162. Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
163. Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
164. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
165. Noninvasive Diagnostic Criteria of the Revised 2014 the Korean Liver Cancer Study Group and the National Cancer Center Guideline for Subcentimetersized Hepatocellular Carcinoma: Is It Too Strict?
166. Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study
167. Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study
168. Laparoscopic Liver Resection of Hepatocellular Carcinoma with a Tumor Size Larger Than 5 cm: Review of 45 Cases in a Tertiary Institution
169. A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
170. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
171. Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
172. Anti-fibrotic effect of bovine colostrum in carbon tetrachloride-induced hepatic fibrosis
173. Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma
174. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
175. Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
176. A Role of Scheduled Second Tace in Early Stage Hepatocellular Carcinoma Showing Complete Response After the First Tace
177. The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
178. Factors Associated With Age-related Hearing Impairment
179. Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study
180. High-Mobility Group Box 1 Is Dispensable for Autophagy, Mitochondrial Quality Control, and Organ Function In Vivo
181. The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population
182. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
183. Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
184. The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
185. Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
186. Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
187. Cause of Mortality for Hepatocellular Carcinoma Patients who were Diagnosed within the Milan Criteria
188. Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
189. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
190. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria
191. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma
192. Corrigendum to “Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease” [Atherosclerosis 234 (2) (2014) 270–275]
193. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
194. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
195. Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis
196. Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
197. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
198. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
199. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population
200. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.